Decreased mortality in acute respiratory distress syndrome patients treated with corticosteroids: an updated meta-analysis of randomized clinical trials with trial sequential analysis – Critical Care  

The post M-A: Decreased mortality in acute respiratory distress syndrome patients treated with corticosteroids appeared first on Links Medicus.

Effect of timing of intubation on clinical outcomes of critically ill patients with COVID-19: a systematic review and meta-analysis of non-randomized cohort studies – Critical Care   Commentary on Twitter Proud to present our meta-analysis of a highly-debated topic! The synthesized evidence of almost 9000 critically ill patients with #COVID_19 suggests that #early_intubation, as suggested […]

The post Effect of timing of intubation on clinical outcomes of critically ill patients with COVID-19: a systematic review and meta-analysis of non-randomized cohort studies appeared first on Links Medicus.

COVID-19, Personal Protective Equipment, and Human Performance – Anesthesiology  

The post COVID-19, Personal Protective Equipment, and Human Performance appeared first on Links Medicus.

COVID associated with hearing loss, tinnitus and vertigo – new study confirms link – The Conversation Original study: One year on: an updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms – International Journal of Audiology  

The post COVID associated with hearing loss, tinnitus and vertigo – new study confirms link appeared first on Links Medicus.

Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial – The Lancet   Commentary on Twitter Less can be more for pneumonia. In 50% CAP patients was possible stop Abx at 3 days and outcomes were the same @TheLancet https://t.co/Hc1AxyndWS pic.twitter.com/Ypk2uXeDQV — […]

The post RCT: Discontinuing β-lactam treatment after 3 days as good as 8 days of treatment for stable patients with community-acquired pneumonia in non-critical care wards appeared first on Links Medicus.

Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review – Cochrane Library   Commentary on Twitter JUST PUBLISHED – Interleukin‐6 blocking agents for treating #COVID19 https://t.co/pt8BNfBwa3 New living systematic review from @Cochrane_ACE looks at the evidence from 10 studies in 6896 people with COVID‐19 pic.twitter.com/hjs97lPBEt — Cochrane UK (@CochraneUK) March 26, 2021  

The post Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review appeared first on Links Medicus.

COVID-19 Is Different Now – The Atlantic  

The post Opinion | COVID-19 Is Different Now: The coronavirus is changing. So is the disease it causes. appeared first on Links Medicus.

The Coronavirus Variants Don’t Seem to Be Highly Variable So Far – Scientific American  

The post Opinion | The Coronavirus Variants Don’t Seem to Be Highly Variable So Far appeared first on Links Medicus.

Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers” – Annals of Clinical and Translational Neurology Commentary: 85% of COVID-19 long-haulers have multiple brain-related symptoms – LiveScience AND ‘Brain fog’ and other neurologic symptoms can last for months after Covid – NBC News AND Neurologic Symptoms Persistent for Many COVID-19 ‘Long-Haulers’ – Health […]

The post Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers” appeared first on Links Medicus.

Covid-19: Middle aged women face greater risk of debilitating long term symptoms – The BMJ Linked Opinion: The stigma is real for people living with long covid – The BMJ Opinion  

The post Covid-19: Middle aged women face greater risk of debilitating long term symptoms appeared first on Links Medicus.